Cogstate Ltd operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Cogstate Ltd with three other companies in this sector in Australia: Clinuvel Pharmaceuticals Limited (2019 sales of 31.61 million Australian Dollars [US$21.65 million] of which 100% was Biotechnology), Mesoblast Ltd (23.40 million Australian Dollars [US$16.03 million] of which 100% was Mesenchymal Precursor Cell), and Benitec Biopharma Limited (16.60 million Australian Dollars [US$11.37 million] ).

Sales Analysis. During the year ended June of 2019, sales at Cogstate Ltd were A$30.58 million (US$20.94 million). This is a decrease of 18.4% versus 2018, when the company's sales were A$37.49 million.